568 related articles for article (PubMed ID: 8797034)
1. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
Hattori K; Orita T; Oheda M; Tamura M; Ono M
In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
[TBL] [Abstract][Full Text] [Related]
2. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Cui X; Shao Y; Ren B; Tong Z; Ren X; Li L; Zhang Z; Zhang N; Dai R; Hao X
Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):247-9. PubMed ID: 11876989
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice.
Kabaya K; Kusaka M; Seki M
In Vivo; 1994; 8(6):1033-9. PubMed ID: 7539636
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of human granulocyte colony-stimulating factor on bacterial and fungal infections in neutropenic mice.
Ono M; Matsumoto M; Matsubara S; Tomioka S; Asano S
Behring Inst Mitt; 1988 Aug; (83):216-21. PubMed ID: 2467649
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor shortens the optimal interval of repetition of chemotherapy with cyclophosphamide in mice.
Hattori K; Tamura M; Ono M
In Vivo; 1996; 10(3):361-8. PubMed ID: 8797041
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF).
Lord BI; Woolford LB; Molineux G
Clin Cancer Res; 2001 Jul; 7(7):2085-90. PubMed ID: 11448927
[TBL] [Abstract][Full Text] [Related]
7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of peripheral blood stem cells by granulocyte-colony stimulating factors: comparison of a standard dose of glycosylated and mutated granulocyte-colony stimulating factor in non-Hodgkin's lymphoma patients following CHOP therapy.
Takemoto Y; Wada H; Takatsuka H; Okamoto T; Kakishita E
Drugs Exp Clin Res; 2000; 26(1):1-5. PubMed ID: 10761530
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
12. [Application of CSF to cancer treatment].
Takaku F
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):739-46. PubMed ID: 2455478
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human granulocyte colony-stimulating factor on the mice receiving bone marrow transplantation following lethal irradiation: acceleration of recovery of the peripheral blood neutrophils and potentiation of anti-Pseudomonas resistance.
Tamura M; Matsumoto M; Yoshino T; Matsubara S; Imai N; Ono M; Yokota T
Exp Hematol; 1991 Jan; 19(1):18-23. PubMed ID: 1703491
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
15. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
Hazar V; Ongun H; Yeşilipek MA; Yeğin O
Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
17. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human granulocyte-colony stimulating factor: in vivo effects on myelopoiesis in primates.
Welte K; Bonilla MA; Gillio AP; Gabrilove JL; O'Reilly RJ; Souza LM
Behring Inst Mitt; 1988 Aug; (83):102-6. PubMed ID: 2467644
[TBL] [Abstract][Full Text] [Related]
20. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF.
de Kruijf EJ; van Pel M; Hagoort H; Kruysdijk D; Molineux G; Willemze R; Fibbe WE
Hum Immunol; 2007 May; 68(5):368-74. PubMed ID: 17462504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]